Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit : 90-Day Results from the INSPIRATION Randomized Trial

enthalten in: Thrombosis and haemostasis | 2022

von Bikdeli, B. | Talasaz, A. | Rashidi, F. | +57

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit : The INSPIRATION Randomized Clinical Trial

enthalten in: JAMA | 2021

von INSPIRATION Investigators | Sadeghipour, P. | Talasaz, A. | +77